Soulaf Abou Khachfe, MD (@soulaf_ak) 's Twitter Profile
Soulaf Abou Khachfe, MD

@soulaf_ak

PGY-1 IM @LoyolaHealth 🇺🇲 Mental Health Advocate

ID: 1485729589322293251

calendar_today24-01-2022 21:42:15

10 Tweet

66 Followers

267 Following

Leonidas Platanias, MD (@leonidasplatan1) 's Twitter Profile Photo

The last 3 years may have been one of the most dramatic & consequential periods in med history. This includes the fastest development ever of life saving technology, mRNA vaccines. At the same time, the most damaging attack ever on vaccines by denialists & other zealots

Soulaf Abou Khachfe, MD (@soulaf_ak) 's Twitter Profile Photo

Thrilled to be staying in Chicago and joining Loyola - MacNeal Internal Medicine Residency for internal medicine residency. Huge thanks to my mentors, family, and friends for their unwavering support. #Match2024 #internalmedicine

Thrilled to be staying in Chicago and joining <a href="/MacNealIMRP/">Loyola - MacNeal Internal Medicine Residency</a> for internal medicine residency. Huge thanks to my mentors, family, and friends for their unwavering support. #Match2024 #internalmedicine
Eric Topol (@erictopol) 's Twitter Profile Photo

Oral Ozempic reduced major adverse cardiovascular events in a large randomized trial of 9,650 participants with T2 diabetes and high-risk NEJM #ACC25 nejm.org/doi/full/10.10…

Oral Ozempic reduced major adverse cardiovascular events in a large randomized trial of 9,650 participants with T2 diabetes and high-risk
<a href="/NEJM/">NEJM</a> #ACC25
nejm.org/doi/full/10.10…
Brendon Neuen (@brendonneuen) 's Twitter Profile Photo

Cardiovascular, Kidney & Mortality Outcomes With Injectable & Oral GLP1-RA in T2 Diabetes An updated meta-analysis of >70,000 patients after the SOUL trial by Matthew MY Lee et al. ⬇️ 14% MACE ⬇️ 14% heart failure ⬇️ 17% CKD ⬇️ 12% all-cause mortality diabetesjournals.org/care/article/d…

Cardiovascular, Kidney &amp; Mortality Outcomes With Injectable &amp; Oral GLP1-RA in T2 Diabetes

An updated meta-analysis of &gt;70,000 patients after the SOUL trial by <a href="/matthewmylee/">Matthew MY Lee</a> et al.

⬇️ 14% MACE
⬇️ 14% heart failure
⬇️ 17% CKD
⬇️ 12% all-cause mortality

diabetesjournals.org/care/article/d…
American Thyroid Association (@amthyroidassn) 's Twitter Profile Photo

April is Hashimoto's Thyroiditis Awareness Month. Did you know that the ATA has a list of Printable/Downloadable Patient Brochures on its website? Learn more about Hashimoto's Thyroiditis: ow.ly/KehQ50VslHC #HashimotosAwarenessMonth #ThyroidEducation

April is Hashimoto's Thyroiditis Awareness Month. Did you know that the ATA has a list of Printable/Downloadable Patient Brochures on its website? 

Learn more about Hashimoto's Thyroiditis: ow.ly/KehQ50VslHC

#HashimotosAwarenessMonth #ThyroidEducation
American Diabetes Association - DiabetesPro (@ada_diabetespro) 's Twitter Profile Photo

🚨 Vaccination is a critical part of protecting those at higher risk for diabetes-related complications. Ensure those managing diabetes are up to date on recommended vaccines. Download our latest infographic to help integrate vaccination into routine care: bit.ly/42b4MB0

🚨 Vaccination is a critical part of protecting those at higher risk for diabetes-related complications. Ensure those managing diabetes are up to date on recommended vaccines. Download our latest infographic to help integrate vaccination into routine care: bit.ly/42b4MB0
Scott Isaacs (@scottisaacsmd) 's Twitter Profile Photo

Overview of clinical evidence for sex-specific effects of GLP-1 analogs and their potential interaction with estrogens. GLP-1 analogs are reshaping diabetes and obesity care, but sex differences in their effects are emerging. Women may experience distinct benefits and side

Overview of clinical evidence for sex-specific effects of GLP-1 analogs and their potential interaction with estrogens. GLP-1 analogs are reshaping diabetes and obesity care, but sex differences in their effects are emerging. Women may experience distinct benefits and side
Soulaf Abou Khachfe, MD (@soulaf_ak) 's Twitter Profile Photo

Honored to be selected for the #ADAScholars Program ahead of #ADA2025 Grateful for 2 incredible days of learning, connection, and inspiration in diabetes care. #adascholars #ADASciSessions American Diabetes Association

Honored to be selected for the #ADAScholars Program ahead of #ADA2025
Grateful for 2 incredible days of learning, connection, and inspiration in diabetes care. 
#adascholars #ADASciSessions <a href="/AmDiabetesAssn/">American Diabetes Association</a>
Claudia Guillén-López MD (@claudiaegl92) 's Twitter Profile Photo

Have you seen the universal lipid screening guidance? Great summary from the NLA! LDL Cholesterol Management Simplified in (Adults) - Lower for Longer is Better: Guidance from the National Lipid Association - Journal of Clinical Lipidology lipidjournal.com/article/S1933-…

Soulaf Abou Khachfe, MD (@soulaf_ak) 's Twitter Profile Photo

Proud to present my two posters at #ENDO2025 in San Fransisco! Grateful for the opportunity to share our work and connect with so many inspiring minds in endocrinology! #ENDO2025 #Endocrinology #Research Loyola - MacNeal Internal Medicine Residency

Proud to present my two posters at #ENDO2025 in San Fransisco! Grateful for the opportunity to share our work and connect with so many inspiring minds in endocrinology! 
#ENDO2025 #Endocrinology #Research <a href="/MacNealIMRP/">Loyola - MacNeal Internal Medicine Residency</a>
Eric Topol (@erictopol) 's Twitter Profile Photo

Metformin, the first line drug for Type 2 diabetes, has been used for 60 years without a clearcut mechanism of action. It turns out it's not just reducing glucose output from the liver. Metformin also works via the brain science.org/doi/10.1126/sc…